台股 » 個股 » 旭富 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

旭富

(4119)
可現股當沖
  • 股價
    85.7
  • 漲跌
    ▲0.9
  • 漲幅
    +1.06%
  • 成交量
    82
  • 產業
    上市 生技醫療類股▼0.22%
  • 353人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
旭富 (4119)籌碼相關-元大-新盛 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-新盛 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/2000.00184.4084.80-1272-0.37%
2025/01/161.183.5600.0084.001.12710.40%
2025/01/100.387.9000.0085.800.32590.12%
2025/01/070.390.6000.0089.800.32470.12%
2025/01/06290.7000.0090.7022460.81%
2025/01/020.189.9000.0090.200.12480.04%
2024/12/27191.5000.0091.3012500.40%
2024/12/13191.1000.0090.6012380.42%
2024/12/0300.00198.0097.80-1216-0.46%
2024/11/20498.25098.3097.8041722.31%
2024/11/18196.0000.0096.0011510.66%
2024/11/14194.5000.0094.9011420.70%
2024/11/1300.000.196.2096.00-0.1136-0.06%
2024/11/1200.00194.4094.30-1123-0.81%
2024/11/050.189.4000.0089.600.1990.07%
2024/10/29289.1000.0089.1021161.72%
2024/10/2300.000.289.0089.00-0.2118-0.15%
2024/10/1400.00190.5090.50-1133-0.75%
2024/08/210.189.1100.0089.400.11800.07%
2024/08/20189.9000.0089.2011810.55%
2024/08/070.190.2000.0090.500.12100.04%
2024/08/050.487.1400.0086.600.42140.18%
2024/08/020.491.1900.0091.000.42050.19%
2024/07/31290.6000.0091.2022040.98%
2024/07/2900.00191.3091.30-1202-0.49%
2024/07/180.292.4000.0092.700.21990.10%
2024/07/170.392.1000.0092.600.31960.14%
2024/07/1100.00291.7091.80-2203-0.98%
2024/07/090.891.4500.0091.800.82050.40%
2024/07/0500.000.291.2491.30-0.2203-0.10%
2024/06/280.190.5000.0090.400.12050.05%
2024/06/130.290.5000.0090.000.22120.09%
2024/06/06193.0000.0092.4012180.46%
2024/06/040.192.0000.0092.500.12280.05%
2024/06/03292.3000.0092.4022310.87%
2024/05/2200.00292.1092.40-2235-0.85%
2024/05/13191.900.291.6691.800.82320.34%
2024/05/1000.000.290.8090.90-0.2240-0.06%
2024/04/190.186.6000.0086.400.12540.02%
2024/04/090.289.1000.0088.900.22610.08%
2024/03/2600.00187.3087.20-1260-0.38%
2024/03/250.187.8000.0087.600.12610.02%
2024/03/1800.001.587.1686.90-1.5284-0.52%
2024/03/150.187.4000.0087.400.12850.02%
2024/03/140.187.7000.0087.200.12860.02%
2024/03/13087.8000.0087.9002850.02%
2024/03/04190.6000.0090.9012740.36%
2024/02/150.189.9000.0089.900.12930.03%
水星生醫*攜手旭富製藥 簽訂MTA開發抗癲癇藥物Anue鉅亨-2024/04/15
旭富新產能到位本季營運看增 觀音新廠產能再增5成Anue鉅亨-2023/10/03
星國阿茲海默三期順利解盲 旭富獨供原料藥營運吞補丸Anue鉅亨-2022/11/23
旭富 相關文章